This allows two possible conclusions: first, impaired GLP-1 secretion is probably associated with the cause or consequence of steatogenesis, as suggested by previous experimental studies [11]–[13], [15]–[19] and is seen as an early event in the pathogenesis of NAFLD. The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.